WASHINGTON — The U.S. commercial turkey industry has faced both significant challenges and remarkable growth this past year. From navigating animal health concerns to responding to shifting consumer preferences, turkey producers have demonstrated resilience and adaptability.
As 2024 unfolds, the industry stands poised to continue its evolution, adapting to new opportunities in international markets and consumer preferences.
Avian Metapneumovirus and Highly Pathogenic Avian Influenza
Avian Metapneumovirus (AMPV) and Highly Pathogenic Avian Influenza (HPAI) are two challenges that have impacted the U.S. turkey industry significantly this past year, underscoring the ongoing need for additional resources and robust. . .